Using molecular tools and early chemical inhibitors, DNA-PK inhibition has been shown to enhance the antitumor effect of ionizing radiation and DSB-inducing chemotherapeutics and was proposed as a new combination strategy for cancer therapy (30, 31). This evidence concerns the gene PRKDC and cancer.